- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 275/42 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
Patent holdings for IPC class C07C 275/42
Total number of patents in this class: 126
10-year publication summary
|
14
|
9
|
13
|
8
|
9
|
14
|
5
|
7
|
3
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4863 |
16 |
| EA Pharma Co., Ltd. | 84 |
6 |
| Allergan, Inc. | 2438 |
5 |
| The Scripps Research Institute | 1353 |
4 |
| Ajinomoto Co., Inc. | 2319 |
3 |
| Catabasis Pharmaceuticals, Inc. | 36 |
3 |
| Daiichi Sankyo Company, Limited | 1864 |
3 |
| OM Pharma | 43 |
3 |
| Vectus Biosystems Limited | 35 |
3 |
| Centre National de La Recherche Scientifique | 10102 |
2 |
| Duke University | 3011 |
2 |
| Centaurus Biopharma Co., Ltd. | 84 |
2 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 670 |
2 |
| Galderma Research & Development | 417 |
2 |
| Lianyungang Runzhong Pharmaceutical Co., Ltd. | 86 |
2 |
| Memorial Sloan-Kettering Cancer Center | 1890 |
2 |
| MethylGene Inc. | 47 |
2 |
| Sanford Burnham Prebys Medical Discovery Institute | 278 |
2 |
| Shenyang Research Institute of Chemical Industry Co., Ltd. | 43 |
2 |
| Tetraphase Pharmaceuticals, Inc. | 50 |
2 |
| Other owners | 58 |